Many organizations conduct trials in the traditional manner using investigator sites, in-person monitoring, and face-to-face engagement, while new approaches have emerged, leveraging technology that has enabled virtual visits and remote patient monitoring. This new innovation has provided new ways to gather critical patient information and create efficiencies which has forged the path for hybrid and decentralized clinical trials.